US district court upholds ViiV HIV patent

19-12-2013

The US District Court for the District of Delaware has upheld the validity of a GSK-held patent that covers two HIV drugs marketed in the US by ViiV Healthcare.


ViiV Healthcare, GSK, Teva, pharmaceuticals, patent validity

WIPR